Fractionation in Radiotherapy

Fractionation in Radiotherapy

Fractionation in Radiotherapy

On this page

Fractionation Fundamentals - Dose Delivery Dance

  • Definition: Dividing total radiotherapy dose into multiple smaller, daily fractions over weeks.
  • Aim: Enhance therapeutic ratio: maximize tumor damage, minimize normal tissue injury.
  • The 4 R's of Radiobiology:
    • Repair: Normal tissues repair sublethal damage (SLD) more efficiently.
    • Reoxygenation: Hypoxic tumor regions gain O₂, ↑ radiosensitivity.
    • Redistribution: Cells enter radiosensitive cell cycle phases (G2/M).
    • Repopulation: Normal cells regenerate; tumor cells too if overall treatment time is protracted.
  • Standard: 1.8-2 Gy/fraction, daily, 5x/week.

⭐ Fractionation primarily exploits differential repair in normal tissues and reoxygenation in tumors, improving therapeutic outcomes.

The 5 R's of Radiobiology - Cell Survival Saga

The biological basis for fractionation's success. 📌 Key principles:

  • Repair: Normal tissues repair Sublethal Damage (SLD) more efficiently than tumors between fractions. Allows normal tissue sparing.
  • Repopulation: Surviving normal and tumor cells divide between fractions. Can be detrimental if tumor repopulation is fast; prolonging treatment time can ↓ local control.
  • Reoxygenation: Hypoxic (radioresistant) tumor core cells gain oxygen access as outer cells die, becoming more radiosensitive.
  • Redistribution (Reassortment): Surviving cells progress through the cell cycle. Fractionation catches more cells in sensitive phases (G2/M).
  • Radiosensitivity: Intrinsic differences in radiation sensitivity among cells and tumor types. Fractionation exploits these differences.

⭐ Reoxygenation is critical: hypoxic cells can be 2-3 times more radioresistant than normoxic cells. Fractionation helps overcome this tumor radioresistance mechanism.

Scheduling Strategies - Time-Dose Tactics

Fractionation exploits differences in repair capacity (one of the 5 R's) between tumor and normal tissues. Based on Linear-Quadratic (LQ) model: $E = n(\alpha d + \beta d^2)$. Biologically Effective Dose (BED) = $D(1 + d/(\alpha/\beta))$ helps compare schedules.

  • α/β ratio: Tumors ≈ 10 Gy (early effects); Late-responding tissues ≈ 3 Gy.
ScheduleDose/Fx (Gy)Fx/DayOverall TimeTotal DoseRationale/Impact
Conventional (CF)1.8-2.016-7 wksStandardStandard; Balanced efficacy & toxicity.
Hyperfractionation (HF)1.1-1.2 (↓)2-3Similar↓ Late toxicity (spares low α/β tissues); ≥6h interval.
Accelerated (AF)Standard/↓≥1↓ (<6 wks)Similar/↓↓ Repopulation in fast tumors; ↑ Acute toxicity.
Hypofractionation (HypoF)>2.5 (↑)1Low α/β tumors (e.g., prostate); Palliative; ↑ Late effects risk.
CHART1.5312 days54 GyContinuous (no weekend break); ↓ Repopulation; ↑ Acute mucosal tox.

LQ Model & BED - Radiobiologic Math

  • Linear-Quadratic (LQ) Model: Predicts cell kill from radiation.
    • Total biological effect: $E = n(\alpha d + \beta d^2)$.
      • $n$: number of fractions, $d$: dose/fraction.
    • $\alpha$ component: irreparable DNA damage (linear cell kill).
    • $\beta$ component: repairable/misrepaired DNA damage (quadratic cell kill).
    • $\alpha/\beta$ ratio: Measures fractionation sensitivity.
      • Tumors & acute effects: ~10 Gy (less sensitive to changes in $d$).
      • Late effects: ~3 Gy (more sensitive to changes in $d$; sparing with lower $d$).
  • Biologically Effective Dose (BED): Total biological impact of a radiotherapy schedule.
    • Formula: $BED = D(1 + d/(\alpha/\beta))$.
      • $D$: total physical dose ($nd$).
    • Allows isoeffective dose calculations for different fractionation regimens.

    ⭐ For late-responding tissues (low $\alpha/\beta$), BED increases significantly with larger fraction sizes ($d$), potentially increasing late toxicity. LQ Model Cell Survival Curve with Alpha/Beta Ratios

High‑Yield Points - ⚡ Biggest Takeaways

  • Fractionation improves therapeutic ratio by exploiting the 4 R's: Repair, Repopulation, Reoxygenation, Redistribution.
  • BED compares schedules using total dose, dose/fraction, and α/β ratio.
  • Late-responding tissues have low α/β ratios (e.g., ~3 Gy), spared by smaller fractions.
  • Tumors & early-responding tissues usually have high α/β ratios (e.g., ~10 Gy).
  • Hyperfractionation (smaller dose/fraction) aims to ↓ late toxicity.
  • Hypofractionation (larger dose/fraction) for palliative care or specific tumors_._

Practice Questions: Fractionation in Radiotherapy

Test your understanding with these related questions

Fractional curettage is done in all except:

1 of 5

Flashcards: Fractionation in Radiotherapy

1/10

The least radiosensitive phase of cell cycle is _____.

TAP TO REVEAL ANSWER

The least radiosensitive phase of cell cycle is _____.

S

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial